Aileron Therapeutics announced that the Company is set to join the Russell Microcap Index at the conclusion of the 2024 Russell U.S. Indexes annual reconstitution, effective at the open of US equity markets on Monday, July 1, 2024.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ALRN:
- Aileron Therapeutics initiated with a Buy at Brookline
- Aileron Therapeutics Announces New Interim CFO Appointment
- Aileron Therapeutics Reports First Quarter 2024 Financial Results and Business Highlights
- Aileron Therapeutics to Present at Two Upcoming Investor Conferences
- Aileron Therapeutics Announces Closing of Underwritten Registered Direct Offering of up to Approximately $40 Million